Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Nicotine replacement therapy beats varenicline for smokers with OUD

Publish date:: June 19, 2019

Key clinical point: Smoking cessation with nicotine replacement vs. varenicline results in less drug use among patients with opioid use disorder.

Major finding: Patients with opioid use disorder had 16.5 drug use days if they used varenicline, compared with 0.13 if they used nicotine replacement therapy at 4-6 months follow-up (P less than .026).

Study details: The findings are based on a randomized, controlled trial of 47 smokers with OUD and 90 smokers without OUD in a smoking cessation program.

Disclosures: The research was funded by the National Institute on Drug Abuse and the Department of Veterans Affairs. The authors reported no disclosures.

Citation:

REPORTING FROM CPDD 2019

This Week's Must Reads

Younger adults present with more advanced esophageal adenocarcinoma,

Osteoporosis prevalence in PsA similar to general population,

Annual WCC visits significantly limit asthma worsening,

U.S. mothers underestimate role breastfeeding plays in curbing breast cancer,

Microplastics permeate human placentas,

Must Reads in Addiction Medicine

E-cigarette use tied to increased COPD, asthma risk,

National lung cancer screening guidelines may miss younger African American individuals at high risk,

Tobacco-free homes yield more tobacco-free youth,

Alcohol problems linked to legal performance-enhancement products,

Report describes intoxication with new psychoactive substance,